Abstract Fractional flow reserve (FFR) during invasive coronary angiography has become an established tool for guiding treatment. However, only one-third of intermediate-grade coronary artery stenosis (ICAS) are hemodynamically significant and require coronary revascularization. Additionally, the severity of stenosis visually established by coronary computed tomography angiography (CCTA) does not reliably correlate with the functional severity. Therefore, additional angiographic morphologic descriptors affecting hemodynamic significance are required. To evaluate quantitative stenosis analysis and plaque descriptors by CCTA in predicting the hemodynamic significance of ICAS and to compare it with quantitative catheter coronary angiography (QCA). QCA was performed in 65 patients (mean age 63 ± 9 years; 47 men) with 76 ICAS (40-70 %) on CCTA. Plaque descriptors were determined including circumferential extent of calcification, plaque composition, minimal lumen diameter (MLD) and area, diameter stenosis percentage (Ds %), area stenosis percentage and stenosis length on CCTA. MLD and Ds % were also analyzed on QCA. FFR was measured on 52 ICAS lesions on CCTA and QCA. The diagnostic values of the best CCTA and QCA descriptors were calculated for ICAS with FFR B 0.80. Of the 76 ICAS on CCTA, 52 (68 %) had a Ds % between 40 and 70 % on QCA. Significant intertechnique correlations were found between CCTA and QCA for MLD and Ds % (p \ 0.001). In 17 (33 %) of the 52 ICAS lesions on QCA, FFR values were B0.80. Calcification circumference extent (p = 0.50) and plaque composition assessment (p = 0.59) did not correlate with the hemodynamic significance. Best predictors for FFR B 0.80 stenosis were B1.35 mm MLD (82 % sensitivity, 66 % specificity), and B2.3 mm 2 minimal lumen area (88 % sensitivity, 60 % specificity) on CCTA, and B1.1 mm MLD (59 % sensitivity, 77 % specificity) on QCA. Quantitative CCTA and QCA poorly predict hemodynamic significance of ICAS, though CCTA seems to have a better sensitivity than QCA. In this range of stenoses, additional functional evaluation is required.
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Introduction
About 7,4 million deaths were due to coronary heart disease in 2012 [1] . Catheter coronary angiography (CCA) is the standard of reference for the evaluation of patients with high pre-test probability for coronary artery disease (CAD), where relevant coronary artery stenosis (CAS) is defined as a diameter reduction C50 %. Nevertheless, CCA is invasive and cannot be recommended as the sole diagnostic test, especially in patients with low-to-intermediate probability for CAD. For these patients, coronary computed tomography angiography (CCTA) is a highly accurate diagnostic alternative, with regards to its correlation with CCA and its high negative predictive value to exclude C50 % stenosis [2, 3] . Meanwhile, to determine the likelihood for lesions' functional significance, the use of a discrete threshold lacks sensitivity, specificity or both [4, 5] . A range of stenosis beyond and above which hemodynamic significance is highly unlikely and likely, respectively, is therefore used in practice. Minimal diameter reduction in the 40-70 % range, the so-called intermediate-grade CAS, is not an uncommon finding on CCA, as it may account for up to 90 % of lesions assuming a Gaussian distribution [6, 7] . Because their visual assessment poorly predicts their functional significance, these lesions require additional workup, including, in some cases, pressure-wire fractional flow reserve (FFR) measurement, the standard Refs. [4, 5, 8, 9] .
Other techniques, such as quantitative coronary angiography (QCA), reportedly provide key anatomical properties of these stenoses, potentially helping decision-making and predicting hemodynamic significance [10] . Interestingly, the same findings can be obtained non-invasively on CCTA [11] . However, the incremental value and influence on the need for functional evaluation or FFR assessment in case of intermediate-grade CAS have received only little attention in the literature. Although a statistical correlation exists between CCTA stenosis descriptors and FFR value, their diagnostic value to predict FFR B 0.80 coronary stenoses was moderate. Furthermore, plaque descriptors such as calcification extent and plaque composition assessment providing a potential advantage of CCTA over QCA were either excluded or not investigated [12] [13] [14] .
In summary, additional angiographic morphologic descriptors affecting hemodynamic significance are required. Therefore, the purpose of this study was to compare the diagnostic performance of CCTA using all stenosis and plaque descriptors to that of QCA in predicting hemodynamic significance of intermediate-grade CAS.
Materials and methods

Patients and study design
This study protocol was approved by the hospital Ethics Committee and all patients gave written informed consent after CCTA diagnosis of at least one intermediate-grade coronary stenosis. The study fully complied with our facility guidelines for cardiovascular disease requiring that vessel stenosis significance should be based on an ''intention to treat'' decision tree [15] . This implies that: (1) reported CAS is quantitatively assessed; (2) all stenoses above 70 % diameter reduction on QCA are considered significant and amenable to treatment; (3) Intermediate CAS should not be considered significant until proven using FFR.
Between September 2009 and November 2012, all patients undergoing CCTA in our institution for intermediate pre-test probability for CAD [16] based on cardiovascular risk factors, clinical examination, ECG, echocardiography and/or exercise ECG, having one or more coronary segment(s) [2 mm in diameter with an intermediate-grade CAS were eligible for this prospective study. All patients were more than 18 years and had no contraindications to X-ray exposure and iodinated contrast agent administration. In addition, they were requested to have no heart rhythm disease and no contraindication to the administration of beta-blockers if their resting HR was [65 beats/min. Figure 1 shows the flowchart of this study. In total, 123 patients were eligible; exclusion criteria were refusal to participate (n = 32), previous stress imaging testing (exercise stress or dobutamine echocardiography, vasodilator or dobutamine MRI, vasodilator or stress exercise stress scintigraphy) in the work up for the symptoms to avoid inclusion bias (n = 21), and unreported myocardial infarct at CCTA (n = 5).
CCTA technique and evaluation
CCTA was performed with a 64-detector CT-scanner (LightSpeed VCT or Discovery CT 750 high-definition, GE Healthcare, Milwaukee, USA). Patients with baseline HR [ 65 beats per min (bpm) were given 5 mg of bisoprolol (Emconcor mitis, Merck, Overijse, Belgium) orally the evening before and the morning of the examination. For the patients with HR remaining [65 bpm an IV bolus of 5-15 mg of metoprolol (Seloken, AstraZeneca, Brussels, Belgium) was given prior to examination.
After placement of an 18-gauge catheter into an antecubital vein, HR and arterial pressure check, the patient was placed on the scan table in dorsal decubitus, chest electrodes were placed and the quality of ECG signal was checked for optimal synchronization. HR was checked again for 2 min. HR variability was defined as the sum of absolute differences between two consecutive heartbeats divided by the number of heartbeats and expressed as mean interbeat difference. Scout imaging was performed and 0.4 mg of sublingual nitroglycerin was administered. Approximately 2 min later, CCTA was acquired during a bolus injection of 70-90 mL of iodinated contrast material (Iomeron 400 mg/ mL, Bracco, Milan, Italia) depending on patient's body mass index (BMI), and followed by a saline chaser of 40 mL at a rate of 4.5-6 mL/s. The appropriate time-window for CCTA acquisition was determined using a stationary sequential axial scanning of 5 mm thickness every 3 s using 40 mA and 100 kV, to detect the contrast bolus arrival at the level of the ascending aorta (SmartPrep; GE Healthcare Milwaukee, USA). CCTA was performed in a craniocaudal direction with a Gantry rotation time of 350 ms, and a 64 9 0.625 mm collimation, allowing a 40 mm coverage per rotation. The tube voltage and the tube current were automatically set between 100 and 120 kV and 400 and 600 mA, respectively, to ensure a diagnostic image quality with the lowest dose, depending on the patient's BMI.
In patients with HR \ 65 bpm and mean interbeat difference \10, a prospective ECG-triggered CCTA was performed (n = 53), allowing radiation dose reduction through a sequential acquisition of 4 consecutive transverse sections with tube-current switched ''on'' only during the 75 %-phase of the 4 RR cycles. Padding of the ''tube-on'' time was used to allow an adaptation to minor HR variations during acquisitions and modify retrospectively the reconstruction window to ensure an identical cardiac phase from one transverse section to another. The padding value was chosen by the operator on the basis of HR fluctuations prior to CCTA, and ranged from 50 ms in patients with stable HR to 100 ms in patients with HR variability close to 10.
In patients with [10 mean interbeat difference and/or HR C 65 bpm (n = 12, 18.5 %), CCTA was acquired using a retrospective ECG-triggered technique and consisted of a helical scanning across all phases of the cardiac cycle, with a continuous table movement and small pitch to ensure multisegment reconstruction of each phase of the cardiac cycle. ECG-controlled tube current modulation was used in all patients, with the peak tube current in mid-diastole and 80 % reduction in systole. The pitch was determined automatically by the system, ranging from approximately 0.2 to 0.3, depending on the HR. Average dose-length product (DLP) and the estimated effective radiation dose (conversion of In all patients, an initial reconstruction was performed at 75 % of the RR interval. The section thickness was 0.625 mm and the increment 0.625 mm with the use of a small-or medium-sized cardiac field of view. In case of motion artifacts on this phase, multiphase reconstructions were obtained for the data acquired with prospective and retrospective ECG triggering techniques, respectively with 5 and 10 % steps, in the ranges of 65-85 and 0-100 % of the RR intervals. Images were reconstructed using a standard reconstruction algorithm.
CCTA image interpretation
Visually, image quality allowed stenosis quantification in all patients. All reconstructed data were evaluated independently by 2 blinded readers (O.G. and A.N.) with [4-year experience in CCTA imaging. The volumetric data displaying the best image quality for each coronary segment was evaluated on a dedicated workstation (AW Volumeshare; GE Healthcare) equipped with software (CardIQ Xpress; GE Healthcare) enabling automatic centerline tracking of all coronary segments. When needed, small manual corrections were made on the centerline and coronary segments were subsequently displayed along their long and short axes. Then a review was performed to evaluate the atherosclerotic plaque on longitudinal and orthogonal reconstructions, with the window and width levels set to approximately 240 and 1200 for lumen and calcification detection. In case of severe calcifications, an additional sharp kernel reconstruction (High spatial resolution kernel, GE Healthcare) was performed to limit blooming artifacts of calcium. In all affected segments, the minimal lumen diameter (MLD) and minimal lumen area (MLA), measured manually using calipers and contour tracing on orthogonal reformations, were reported to the average between proximal and distal diameters and areas to the plaque, in order to define respectively minimal diameter and area stenosis percentages (Ds % and As %) (Fig. 2) . In ostial lesions, only the distal reference site was used. Stenosis length (Ls) was measured on longitudinal reformations, from the start to the end of the narrowing. A semi-quantitative plaque composition assessment was performed using a 4-point scale: (1) soft (no calcification); (2) mixed with predominant soft component, (3) mixed with predominant calcified component, and (4) completely Personal History of heart disease, n (%) 8 (12) Diabetes mellitus, n (%) 14 (22) Smoking, n (%) 24 (37) Hyperlipidemia, n (%) 44 (68) Hypertension, n (%) 44 (68) calcified. Orthogonal reformations were used to grade the highest coronary segment calcification circumference as: low (\25 % of the circumference), mild (\50 % of the circumference), high (\75 % of the circumference) and very high ([ 75 % of the circumference). To compare CCTA with QCA, the average quantitative data of both readings were used for MLD, MLA, Ds %, As %, reference diameter and area, and Ls, while consensus readings were performed to resolve all discordant qualitative findings (plaque composition and calcification circumference extent).
QCA and pressure wire-derived FFR CCA was performed after catheterization of a common femoral artery using a 7-French catheter, after 100-200 lg intracoronary nitroglycerin infusion, with at least 2 orthogonal projections for all segments as described in the AHA guidelines (3). All cineangiographies (Hexabrix 320 mgI/mL, Guerbet, Aulnay-Sous-Bois, France) were recorded on digital supports. A registry was made of the material used like catheters, guides, balloons, stents, and pressure guides, if applicable. QCA was performed with the Xcelera R3.1L1 system (Philips Medical Systems, Best, The Netherlands). Intracoronary pressure wire-derived FFR was measured using a 0.014 inch pressure wire with a pressure-sensing guidewire system (FloWire Ò Doppler Guide Wire image Volcano Corporation). After placement of the pressure sensor tipped coronary angioplasty guide wire across the coronary stenosis, the absolute distal pressure was recorded at rest and at maximal myocardial hyperemia, i.e. 30-60 s after intracoronary injection of 15-20 mg of papaverine (papaverine STEROP 100 mg/3 mL).
The data provided by both QCA and FFR for the selected intermediate-grade stenosis include the diameter of reference, MLD at peak stenosis, Ds % and the FFR value.
Statistical analysis
Continuous data were expressed as mean ± standard deviation (SD). Cohen's Kappa and intraclass correlation (ICC) statistics were used to assess the readers' concordance for plaque composition and calcification circumference extent and quantitative measurements on CCTA, respectively. Bland-Altman statistics were used to assess the concordance between CCTA and QCA assessment of the MLD and Ds %. Fischer and Wilcoxon Rank Sum test were used to evaluate the respective distribution of qualitative and non qualitative variables according to hemodynamic significance. Receiver operator characteristics (ROC) statistics were used to determine the diagnostic performance of CCTA and QCA descriptors in predicting FFR B 0.8 stenosis. A p value of less than 0.05 was considered to express a statistically significant difference. Tables 2 and 3 , respectively; the interreader concordances (kappa values range; 0.88-0.92) and correlations (ICC range; 0.79-0.96) were excellent. Plotting MLD and Ds % on CCTA using QCA as the standard of reference showed an excellent inter-technique correlation. However, average inter-technique difference increased significantly for MLD (Fig. 3a) and Ds % (Fig. 3b) (p \ 0.001) .
On QCA, 12/76 (16 %) lesions were above the 70 % Ds % threshold (average 78.2 ± 5.1 %), and 12/76 (16 %) below the 40 % Ds % threshold (average 34.9 ± 2.4 %). The respective rate of entirely soft lesions, highly to very highly calcified lesions and ostial lesions did not vary significantly among appropriately graded, undergraded and overgraded CAS on CCTA (Table 4) . Table 5 . Lesion location, calcification circumference, plaque composition sub-categorization, reference diameter, reference area, Ds %, As %, and Ls distributions were not statistically different between the two groups (all p values [0.05) while CCTA-based MLD (p = 0.030) and MLA 
Prediction of hemodynamic significance
Discussion
Generally thought, CCTA has a high negative predictive value in excluding significant CAS using a 50 % threshold [17, 18] . Paradoxically, when it comes to stenosis grade correlation with QCA, quantitative CCTA is often subject to both over-and underestimation [4, 12] . Our data were consistent with these data, with a total number of 24/76 (32 %) stenoses out of the intermediate severity range on QCA, with a good balance between overestimation (12/24 with \40 % stenosis) and underestimation (12/24 with [70 % stenosis). The respective advantages of CCA over CCTA and vice versa may theoretically cause these stenosis grade discrepancies. Of note, the spatial resolution of CCTA is lower as compared to CCA, especially in case of calcified lesions [19] [20] [21] , but CCTA is superior to CCA for assessing eccentric, ostial or tortuous lesions [5] . Nevertheless, we found no convincing effect of the distribution of calcified plaques, ostial and angulated lesions on the rate of misclassified and correctly classified lesions. An explanation for the poor intertechnique categorical stenosis grade agreement came from the continuous lesion descriptors (such as MLD and Ds %) agreement assessment. Although some studies reported only moderate [22] or weak [23] correlations between CCTA and QCA, we found significant correlations between both techniques similarly to Meijboom et al. [4] and Voros et al. [24] . In addition, the inter-technique difference increased The minimal lumen diameter (MLD) and minimal lumen area (MLA) at the level of the stenosis were respectively 1.6 mm and 2.9 mm 2 (c) on orthogonal reformats, resulting in a 59 % diameter narrowing when reported to the proximal reference diameter (b), while FFR value was 0.61. CCTA coronary computed tomography angiography; stenosis, QCA quantitative coronary angiography, CCA catheter coronary angiography, FFR fractional flow reserve significantly with the percentage stenosis as a result of a stenosis range bias between CCTA and QCA, meaning that stenoses at the limits of the range on CCTA would be automatically underestimated or overestimated on QCA.
As we observed, the corollary of a good intertechnique correlation for MLD and Ds % is that CCTA shares the known limitations of QCA in the prediction of hemodynamic significance using these descriptors [4, 9] , meanwhile there was a slightly higher sensitivity for quantitative CCTA as compared to QCA. The ability to evaluate plaque composition and length, degree of calcification, MLA and As % are other potential advantages of CCTA over QCA; given these advantages, this study did not show any increment of the prediction of hemodynamic significance using these variables even with a combination of different descriptors. In addition, the cut-off values of quantitative imaging descriptors for hemodynamic significance are vessel-size dependent and therefore, highly variable according to the location and the vasotone [24, 25] . For example, in our study, 2.3 mm 2 MLA was the best predictor of FFR B 0.8, with a sensitivity and specificity of 88 and 60 % respectively. Our cut-off value, though similar to the 2.2 mm 2 reported by Doh et al. [13] , is slightly higher to the 1.8 mm 2 reported by Kristensen et al. [26] , and lower than the 3.0 mm 2 reported by Opolski et al. [14] . The lesion rate of FFR B 0.8 was 17/52 (33 %). This is within the range reported in previous studies assessing specifically intermediate-grade CAS on CCA [27, 28] and on CCTA [13] . However, our reported prevalence was substantially higher than the rate of 18 % (10/56) reported by Kristensen et al. [26] but lower than the rate of 45 % reported by Rossi et al. [12] . This difference in prevalence is mainly due to differences in FFR cut-off, patient selection and the mode of stenosis assessment (visual or quantitative) on CCTA. With regard to the increasing use of CCTA in patients with low to intermediate pre-test probability for CAD [29] , the observed test-positive rate places increasing pressure on the diagnostic strategies for hemodynamic significance.
A limitation of this study may be the relatively low number of patients included. Our few data missed some challenging but not uncommon lesions, such as long ([15 mm) or multiple successive stenoses. However, in our study, patients with intermediate-grade CAS were enrolled in a guideline-compliant clinical decisional algorithm to determine the hemodynamic significance outcome of these lesions based on stenosis and plaque descriptors analyses from both quantitative CCTA and QCA. Indeed, the 181 and 71 coronary artery lesions reported in the prospective study of Doh et al. [13] and Opolski et al. [30] . respectively, were included on the basis of a visual analysis of CCA and CCTA. The 85 lesions recently described by Rossi et al. [12] resulted from a retrospective assessment. Because of our study design, no FFR assessment was available in 24/76 lesions. However, this study was undertaken in accordance with clinical practice guidelines defining the need for coronary revascularization in lesions with minimal diameter stenosis C70 % or positive FFR assessment [15] . In current practice, CCTA morphological descriptors of lesion stenosis are daily used to determine the likelihood for a coronary lesion to be of hemodynamic significance. Although CCTA may perform well to determine the likelihood of hemodynamic significance in high-and low-grade stenoses, our work adds to the current knowledge that this may be untrue in the intermediate-severity range. Furthermore, this also applies to QCA, as CCTA seems to perform slightly better. In addition, we used a specific manufacturer workstation and could not guarantee that other workstations would provide strictly identical results. Lastly, we did not assess 
Conclusions
Quantitative CCTA and QCA poorly predict the hemodynamic significance of intermediate CAS, though CCTA seems to have a better sensitivity than QCA. In this range of stenoses, additional functional evaluation is required. New clinical and cost effective functional evaluation strategies and guidelines are needed, especially with regard to the increasing use of CCTA in patients with low-tointermediate probability for CAD.
